Conclusion

Some evidence shows that HIV-1 itself changes the predilection for stroke, whose causes are also related to the immunosup­pression, to the risk behaviors for HIV-1 infection, and to the metabolic effects of combined therapies, especially those with PIs.

References

1. Malouf R, Jacquette G, Dobkin J, Brust JCM (1990) Neurologic disease in human immunode­ficiency virus-infected drug abusers. Arch Neurol 47:1002-1007

2. Moulignier A (2006) HIV and the central nervous system. Rev Neurol (Paris) 162:22-42

3. Moulignier A, Moulonguet A (2007) Complica­tions neurologiques. In: Katalama C, Girard P-M, Pialoux G (eds) VIH 2007. Doin, Reuil Malmaison, pp 97-133

4. Sacktor N (2002) The epidemiology of human im­munodeficiency virus-associated neurological dis­ease in the era of highly active antiretroviral ther­apy. J Neurovirol 8(Suppl 2):115-121

5. Gray F, Bazille C, Addle-Biassette H et al (2005) Central nervous system immune reconstitution disease in AIDS patients receiving highly active antiretroviral treatment. J Neurovirol 11(Suppl 3):16-22

6. Scaravilli F, Bazille C, Gray F (2007). Neuropatho- logic contributions to understanding AIDS and the central nervous system.

7. Jellinger KA, Setinek U, Drlicek M et al (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213-220

8. Snider WD, Simpson DM, Nielsen S et al (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403-418

9. Rabinstein AA (2003) Stroke in HIV-infected pa­tients: a clinical perspective. Cerebrovasc Dis 15:37-44

10. Kamin DS, Grinspoon SK (2005) Cardiovascular disease in HIV-positive patients. AIDS 19:641-652

11. d’Arminio Monforte A, Bongiovanni M (2005) Cerebrovascular disease in highly active anti­retroviral therapy-treated individuals: incidence and risk factors. J Neurovirol 11(Suppl 3):34-47

12. Moulignier A (2007) Dementia due to HIV disease and aging. Psychol Neuropsychiatr Vieil 5:1-15

13. Pinto AN (1996) AIDS and cerebrovascular dis­ease. Stroke 27:538-543

14. Ortiz G, Koch S, Romano JG et al (2007) Mecha­nisms of ischemic stroke in HIV-infected patients. Neurology 68:1257-1261

15. Tipping B, de Villiers L,Wainwright H et al (2007) Stroke in patients with human immunodeficien­cy virus infection. J Neurol Neurosurg Psychiatry 78:1320-1324

16. Cole JW, Pinto AN, Hebel JR et al (2004) Ac­quired immunodeficiency syndrome and the risk of stroke. Stroke 35:51-56

17. Levy RM, Bredesen DE (1988) Central nervous system dysfunction in acquired immunodeficien­cy syndrome. J Acquir Immune Defic Syndr 1:41-64

18. Evers S, Nabavi D, Rahmann A et al (2003) Is­chaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc Dis 15:199-205

19. Hoffmann M, Berger JR, Nath A, Rayens (2000) Cerebrovascular disease in young, HIV-infected black Africans in the KwaZulu natal province of South Africa. J Neurovirol 6:229-236

20. d’Arminio A, Sabin CA, Phillips AN et al; Writing Committee of the DAD Study Group (2004) Car­dio- and cerebrovascular events in HIV-infected persons. AIDS 18:1811-1817

21.

22. Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular out- c omes in p atient s wit h H IV- 1. Lanc et 306:1747-1748

23. Levy RM, Bredesen DE, Rosenblum ML (1985) Neurological manifestations of the acquired im­munodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62:475-495

24. Koppel BS, Wormser GP_jTuchman AJ et al (1985) Central nervous system involvement in patients with acquired immunodeficiency syndrome

(AIDS). Acta Neurol Scand 71:337-353

25. Berger JR, Moskowitz L, Fischl M, Kelley RE (1987) Neurological disease as the presenting manifestation of acquired immunodeficiency syn­drome. South Med J 80:683-686

26. McArthur JC (1987) Neurological manifestations of AIDS. Medicine 66:407-437

27. Engstrom JW, Lowenstein DH, Bredesen DE (1989) Cerebral infarctions and transient neuro­logic deficits associated with acquired immun­odeficiency syndrome. Am J Med 86:528-532

28. Moskowitz LB, Hensley GT, Chan JC et al (1984) The neuropathology of acquired immunodeficien­cy syndrome. Arch Pathol Lab Med 108:867-872

29. Anders KH, Guerra WF, Tomiyasu U,Vinters HV (1986) The neuropathology of AIDS: UCLA expe­rience and review. Am J Pathol 124:537-558

30. Rosemberg S, Lopes MBS, Tsanadis AM (1986) Neuropathology of acquired immunodeficiency syndrome: analysis of 22 Brazilian cases. J Neu­rol Sci 76:187-198

31. Mizusawa H, Hirano A, Llena SF, Shintaku M (1988) Cerebrovascular lesions of AIDS. Acta Neu- ropathol 76:451-457

32. Esiri MM, Scaravilli F, Millard PR, Harcourt-Web­ster JN (1989) Neuropathology of HIV infection in hemophiliacs: comparative necropsy study. Br Med J 299:1312-1315

33. Berger JR, Harris JO, Gragorios J, Norenberg M (1990) Cerebrovascular disease in AIDS: a case control study.

34. Kieburtz KD, Eskin TA, Ketonen L, Tuite MJ (1993) Opportunistic cerebral vasculopathy and stroke in patients with AIDS. Arch Neurol 50:430-432

35. Connor MD, Lammie GA, Bell JE et al (2000) Cerebral infarction in adult AIDS patients: obser­vations from the Edinburgh HIV Autopsy Cohort. Stroke 31:2117-2126

36. Gillams AR, Allen E, Hrieb K et al (1997) Cere­bral infarction in patients with AIDS. Am J Neu­roradiol 18:1581-1585

37. Grindal AB, Cohen RJ, Saul RF et al (1978) Cere­bral infarction in young adults. Stroke 9:39-42

38. Kristensen B, Malm J, Carlberg B et al (1997) Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 28:1702-1709

39. Berger K, Schulte H, Stogbauer F, Assmann G (1998) Incidence and risk factors for stroke in an occupational cohort: the PROCAM study. Stroke 29:1562-1566

40. Qureshi AI, Janssen RS, Karon JM et al (1997) Hu­man immunodeficiency virus infection and stroke in young patients. Arch Neurol 54:1150-1153

41. Bajwa ZH, Libman R, Lipton RB et al (1991) Cere­brovascular disease in patients with HIV. Neurol-

ogy 41(Suppl 1):S295

42. Baily GG, Mandal BK (1995) Recurrent transient neurological deficits in advanced HIV infection. AIDS 9:709-712

43. Brew BJ, Miller J (1996) Human immunodeficien­cy virus type 1-related transient neurological deficits. Am J Med 10:257-261

44. Rinaldi R, Manfredi R, Azzimondi G et al (1997) Recurrent ‘migrainelike’ episodes in patients with HIV disease. Headache 37:443-448

45. Klein JL, Price DA, Fisher M, Coker RJ (1996) Cy­tomegalovirus infection: a possible cause of recur­rent transient neurological dysfunction in ad­vanced HIV infection. AIDS 10:345-346

46. Card T,Wathen CG, Luzzi GA (1998) Primary HIV- 1 infection presenting with transient neurologi­cal deficit. J Neurol Neurosurg Psychiatry 6:281-282

47. Atalaia A, Ferro J, Antunes F (1992) Stroke in an HIV-infected patient J Neurol 239:356-357

48.

49. Zunker P, Nabavi DG, Allardt A et al (1996) HIV- associated stroke: report of two unusual cases. Stroke 27:1694-1696

50. Vittecoq D, Escaut L, Monsuez JJ (1998) Vascular complications associated with use of HIV pro­tease inhibitors. Lancet 351:1959

51. Casado-Naranjo I, Toledo-Santos JA, Antolin-Ro- driguez MA (1992) Ischemic stroke as the sole manifestation of HIV infection. Stroke 23:117-118

52. Mochan A, Modi M, Modi G (2003) Stroke in black South African HIV-positive patients: a prospective analysis. Stroke 34:10-15

53. Roldan EO, Moskowitz L, Hensley GT (1987) Pathology of the heart in acquired immunodefi­ciency syndrome. Arch Pathol Lab Med 111:943-946

54. Lai WW, Colan SD, Easley KA et al (2001) Dila­tion of the aortic root in children infected with hu­man immunodeficiency virus type 1: The Prospec­tive P2C2 HIV Multicenter Study. Am Heart J 141:661-670

55. Anders KH, Latta H, Chang BS et al (1989) Lym- phomatoid granulomatosis and malignant lym­phoma of the central nervous system in the ac­quired immunodeficiency syndrome. Hum Pathol 20:326-334

56. Geier SA, Perro C, Klauss V et al (1993) HIV-re­lated ocular microangiopathic syndrome and cog­nitive functioning. J Acquir Immune Defic Syn- dr 6:252-258

57. Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ (1989) Chronic basal meningitis and vasculitis in acquired immunodeficiency syn­drome: a possible role for human immunodeficien­cy virus. Arch Pathol Lab Med 113:192-195

58. Yankner BA, Skolnik PR, Shoukimas GM et al (1986) Cerebral granulomatous angiitis associat­ed with isolation of human T-lymphotropic virus type III from the central nervous system. Ann Neurol 20:362-364

59. Nogueras C, Sala M, Sasal M et al (2002) Recur­rent stroke as a manifestation of primary angiitis of the central nervous system in a patient infect­ed with human immunodeficiency virus. Arch Neurol 59:468-473

60.

61. Brannagan TH (1997) Retroviral-associated vas­culitis of the nervous system. Neurol Clin 15:927-944

62. van der Ven AJ, van Oostenbrugge RJ, Kubat B,Ter- vaert JW (2002) Cerebral vasculitis after initia­tion of antiretroviral therapy. AIDS 16:2362-2364

63. Dehais C, Moulignier A, Deschamps R et al (2004) Immune reconstitution vasculitis in an HIV-in­fected patient (abstract). Program of the Journees de Neurologie de Langue Frangaise, Strasbourg

64. Moulignier A, Laloum L, Chauveau E et al (2003) HIV-1-related ischaemic trochlear nerve palsy. J Neurol 250:108-109

65. Brilla R, Nabavi DG, Schulte-Atedorneburg G et al (1999) Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: a pilot study. Stroke 30:811-813

66. Tran Dinh YR, Mamo H, Cervoni J et al (1990) Dis­turbances in the cerebral perfusion of human im­mune deficiency virus-1 seropositive asympto­matic subjects: a quantitative tomography study of 18 cases. J Nucl Med 31:1601-1607

67. Tipping B, de Villiers L, Candy S, Wainwright H (2006) Stroke caused by human immunodeficien­cy virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol 63:1640-1642

68. Feldman JG, Goldwasser P, Holman S et al (2003) C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Ac- quir Immune Defic Syndr 32:210-214

69. Rhew DC, Bernal M, Aguilar D et al (2003) Asso­ciation between protease inhibitor use and in­creased cardiovascular risk in patients infected with human immunodeficiency virus: a systemat­ic review. Clin Infect Dis 31:959-972

70. Maggi P, Serio G, Epifani G et al (2000) Premature lesions of the carotid vessels in HIV-1-infected pa­tients treated with protease inhibitors. AIDS 14:123-128

71. de Saint Martin L, Vandhuic O, Guillo P et al (2006) Premature atherosclerosis in HIV positive patients and cumulated time of exposure to an­tiretroviral therapy (SHIVA study). Atherosclero-

sis 185:361-367

72. Seminari E, Pan A,Voltini G et al (2002). Assess­ment of atherosclerosis using carotid ultrasonog­raphy in a cohort of HIV-positive patients treat­ed with protease inhibitors. Atherosclerosis 162:433-438

73. Mercie P_jThiebaut R, Aurillac-Lavignolle V et al (2005) Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 6:380-387

74. Depayron M, Chessex S, Sudre P et al (2001) Pre­mature atherosclerosis in HIV-infected individu­als: focus on protease inhibitor therapy. AIDS 15:329-334

75. Jerico C, Knobel H, Calvo N et al (2006) Subclin- ical carotid atherosclerosis in HIV-infected pa­tients: role of combination antiretroviral therapy. Stroke 37:812-817

76. Hsue PY, Lo JC, Franklin A et al (2004) Progres­sion of atherosclerosis as assessed by carotid in­tima-media thickness in patients with HIV infec­tion. Circulation 109:1603-1609

77. Thiebaut R, Aurillac-Lavignolle V, Bonnet F et al (2005). Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine cohort, 1999-2004. AIDS 19:729-731

78. Currier JS, Kendall MA, Henry WK et al (2007) Progression of carotid intima-media thickening in HIV-infected and uninfected adults. AIDS 21:1137-1145

79. Hollander M, Hak AE, Koudstaal PJ et al (2003) Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 34:2367-2372

80. Van Oijen M, de Jong FJ, Witteman JCM et al (2007) Atherosclerosis and risk for dementia. Ann Neurol 61:403-410

81. Bock AR, Schwab J, Marienhagen J et al (1994) Anticardiolipin antibodies in HIV infection: asso­ciated with cerebral perfusion defects as detect­ed by 99mTc-HMPAO SPECT. Clin Exp Immunol 98:361-368

82. Brey RL, Chapman J, Levine SR et al (2003) Stroke and the antiphospholipid syndrome: con­sensus meeting,Taormina 2002. Lupus 12:508-513

83. Hassell KL, Kressin DC, Neumann A, Ellison R, Marlar RA (1994) Correlation of antiphospho­lipid antibodies and protein S deficiency with thrombosis in HIV-infected men. Blood Coagul Fibrinolysis 5:455-462

84. Mochan A, Modi M, Modi G (2005) Protein S de­ficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection. J Neurol Neu- rosurg Psychiatry 76:1455-1456

85. Martin CM, Matlow AG, Chew E et al (1989) Hy­perviscosity syndrome in a patient with acquired immunodeficiency syndrome. Arch Intern Med

149:1435-1436

86. Bruno A (2003) Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep 3:40-45

87. Hanyu S, Ikeguchi K, Imai H et al (1995) Cerebral infarction associated with 3,4-methylene- dioxymethamphetamine (‘ecstasy’) abuse. Eur Neurol 35:173

88. Strobel M, Lamaury I, Brouzes F et al (1995) Ac­cidents vasculaires cerebraux et sida. Rev Med In­terne 16:743-746

89. Moulignier A, Baudrimont M, Martin-Negrier ML et al (1996) Fatal brain stem encephalitis due to herpes simplex virus type 1 in AIDS. J Neurol 243:491-493

90. Brust JC (2002) Neurologic complications of sub­stance abuse. J Acquir Immune Defic Syndr 31(Suppl 2):S29-S34

91. Nolte KB, Brass LM, Fletterick CF (1996) Intracra­nial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 46:1291-1296

92. Buttner A, Mall G, Penning R, Sachs H, Weis S (2003) The neuropathology of cocaine abuse. Leg Med 5(Suppl 1):S240-242

93. Cohen JE, Eger K, Montero A, Israel Z (1998) Rapid spontaneous resolution of acute subdural hematoma and HIV related cerebral atrophy: case report. Surg Neurol 50:241-244

94. Jordan BD, Navia BA, Petito C et al (1985) Neu­rological syndromes complicating AIDS. Front Radiat Ther Oncol 19:82-87

95. Meyohas MC, Roullet E, Rouzioux C et al (1989) Cerebral venous thrombosis and dual primary in­fection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 52:1010-1011

96. Doberson MJ, Kleinschmidt-DeMasters BK (1994) Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 118:844-846

97. Iranzo A, Domingo P, Cadafalch J, Sambeat MA (1998) Intracranial venous and dural sinus throm­bosis due to protein S deficiency in a patient with AIDS. J Neurol Neurosurg Psychiatry 64:688

98. Berger JR, Harris JO, Gregorios J, Norenberg M (1990) Cerebrovascular disease in AIDS: a case control study. AIDS 4:239-244

99. Afsari K, Frank J,Vaksman Y, Nguyen TV (2003) Intracranial venous sinus thrombosis complicat­ing AIDS-associated nephropathy. AIDS Read 13:143-148

100. Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W (2001) Cerebral ergotism under treat­ment with ergotamine and ritonavir. Neurology 57:743-744

101. Martinez E, Collazos J, Mayo J (1998) Shock and cerebral infarct after rifampicin re-exposure in a patient infected with human immunodeficiency virus. Clin Infect Dis 27:1329-1330

102. Carvalho Felicio A, Sampaio G, Celso dos Santos WA et al (2006) Spontaneous artery dissection in a patient with human immunodeficiency virus infection. Arq Neuropsiquitr 64:306-308

103. Fenelon G, Gray F, Scaravilli F et al (1991) Is­chemic myelopathy secondary to disseminated intravascular coagulation in AIDS. J Neurol 238:51-54

104. Gray F, Belec L, Lescs MC (1994) Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 117:987-999

105. Kenyon LC, Dulaney E, Montone KT et al (1996) Varicella-zoster ventriculo-encephalitis and spinal cord infarction in a patient with AIDS. Acta Neu- ropathol 92:202-205

106. Park YD, Belman AL, Kim TS et al (1990) Stroke in pediatric acquired immunodeficiency syn­drome. Ann Neurol 28:303-311

107. Patsalides AD, Wood LV, Atac GK et al (2002) Cerebrovascular disease in HIV-infected pedi­atric patients: neuroimaging findings. Am J Roentgenol 179:999-1003

108. Visudtibhan A, Visudhiphan P, Chiemchanya S (1999) Stroke and seizures as the presenting signs of pediatric HIV infection. Pediatr Neurol 20:53-56

109. Husson RN, Saini R, Lewis LL et al (1992) Cere­bral artery aneurysms in children infected with human immunodeficiency virus. J Pediatr 121:927-930

110. Kure K, Llena JF, Lyman WD et al (1991) Human immunodeficiency virus-1 infection of the nerv­ous system: an autopsy study of 268 adult, pedi­atric, and fetal brains. Hum Pathol 22:700-710

111. Lang C, Jacobi G, Kreuz W et al (1992) Rapid de­velopment of giant aneurysm at the base of the brain in an 8-year-old boy with perinatal HIV in­fection. Acta Histochem (Suppl) 42:83-90

112. Bonnet D, Aggoun Y, Szezepanski I et al (2004) Ar­terial stiffness and endothelial dysfunction in HIV-infected children. AIDS 18:1037-1041

113. Mazzoni P, Chiriboga CA, Millar WS, Rogers A (2000) Intracerebral aneurysms in human immun­odeficiency virus infection: case report and liter­ature review. Pediatr Neurol 23:252-255

114. McComsey GA, O’Riordan MA, Hazen SL et al (2007) Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 21:921-927

115. Vilaseca MA, Sierra C, Colome C et al (2001) Hy- perhomocysteinaemia and folate deficiency in human immunodeficiency virus-infected children. Eur J Clin Invest 31:992-998